Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Nolwenn Juhel »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nobutaka Hattori < Nolwenn Juhel < Norbert Kovacs  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000200 (2010) Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000322 (2007) Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis]Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Aged
2Double-Blind Method
2Female
2Humans
2Male
2Middle Aged
2Nervous system diseases
2Parkinson Disease (drug therapy)
2Parkinson disease
2Parkinson's disease
2Treatment
2treatment
1Antiparkinson Agents (administration & dosage)
1Antiparkinson Agents (adverse effects)
1Antiparkinson Agents (therapeutic use)
1Benzothiazoles (administration & dosage)
1Benzothiazoles (adverse effects)
1Benzothiazoles (therapeutic use)
1Bicyclo Compounds, Heterocyclic (therapeutic use)
1Clinical trial
1Delayed-Action Preparations (administration & dosage)
1Delayed-Action Preparations (adverse effects)
1Delayed-Action Preparations (therapeutic use)
1Dopamine
1Dopamine agonist
1Dose-Response Relationship, Drug
1Drug Administration Schedule
1Evaluation
1Levodopa (therapeutic use)
1NS 2330
1Neurotransmitter Uptake Inhibitors (therapeutic use)
1Patient Satisfaction
1Pramipexole
1Quality of Life
1Release
1Retrospective Studies
1Reuptake inhibitor
1Severity of Illness Index
1Tesofensine
1Treatment Outcome
1clinical trial
1dopamine agonist
1dopamine reuptake inhibitor
1dopamine transporter
1monotherapy
1pramipexole extended release
1tesofensine

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Nolwenn Juhel" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Nolwenn Juhel" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Nolwenn Juhel
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024